Has Mounjaro Come Down in Price in the UK?

What the price rise was, and why it happened

The jump in September 2025 wasn't a small adjustment. Eli Lilly's UK list price for the highest-dose Mounjaro pen moved from roughly £122 to roughly £330, a change that rippled through every private provider almost immediately. Lower doses saw smaller increases, but the direction was consistent across the range. As widely reported in August 2025 ahead of the change, Lilly cited manufacturing investment and the cost of bringing tirzepatide through the UK regulatory process as context.

That list price is the floor, not the ceiling. Private pharmacies and clinics set their own retail prices, which is why the figures you'll see quoted across the market (roughly £149 to £375 per month depending on dose and supplier) span a meaningful range. NICE's appraisal of tirzepatide (TA1026) gives useful background on the clinical evidence and how the medicine was assessed, but it doesn't set private pricing. The price you pay privately is a commercial decision made by each provider.

For a fuller picture of how the cost has moved over time, and what forecasters expect next, our dedicated page on Mounjaro pricing in the UK tracks the latest figures with context. If you're wondering whether Mounjaro has gone down in price at any point since the September rise, the short answer is that a price correction downward hasn't happened, and there's no confirmed date for one.

What headline prices often leave out

The quoted monthly figure from many providers covers the pen. That's it. Consultation fees, prescription fees, clinical support between doses, dose-increase reviews and delivery can all be billed separately, sometimes visibly, sometimes buried in the small print. A patient paying £149 for a pen plus £25 for the consultation, £10 for the prescription and £6 for delivery is actually spending £190. That kind of arithmetic matters when you're comparing options.

It's also worth knowing that these are not one-and-done purchases. Mounjaro is titrated over months, starting at 2.5mg as the body adjusts, then stepping upward under prescriber guidance. Each dose increase, per NICE TA1026 and the medicine's licensed use, requires clinical review. Some providers charge separately for that. Others bundle it. Knowing which you're dealing with before you start is straightforward: ask what's included in the monthly price, in writing, before you commit.

If you're trying to map your likely costs across the titration schedule, our overview of what Mounjaro costs across the dose range breaks that down honestly, including what a full titration course might look like financially.

Where nume sits on price, and why

We're not going to be the cheapest option you find. That's a deliberate choice, not an oversight. One transparent price at nume covers the clinical consultation, the prescription, the medicine, and free next-working-day tracked delivery via DPD. Aftercare and clinical re-review before every repeat order are included too. There is no subscription locking you in; every order is reviewed individually by a named prescriber, not processed automatically.

A real clinician (a GPhC-registered Independent Prescriber) reads your consultation the same day. Not software. Not a checklist sent to a queue. You can verify our pharmacy on the GPhC register directly: our registration number is 9012878, searchable on the pharmacyregulation.org register. That kind of infrastructure has a cost, and we'd rather be honest about that than shave the number and cut something that matters.

Current treatment prices are shown on our weight-loss treatments page. We don't run discount codes, voucher schemes or promotional offers on prescription medicines, and if you see a code being advertised elsewhere for Mounjaro or any other weight-loss injection, that's worth treating as a warning sign rather than a bargain.

Why price is the wrong place to start for a prescription medicine

There's a practical reason the MHRA has issued repeated warnings about counterfeit weight-loss pens sold online: cheap supply and safe supply are not the same thing. In October 2025, enforcement teams raided an illicit manufacturing site in Northampton producing fake tirzepatide pens, part of a broader crackdown that saw approximately 20 million doses of illegally traded weight-loss medicines, worth around £45 million, seized in the UK that year. Fake pens have previously been found to contain insulin.

The MHRA's public guidance on reporting suspect sellers via Yellow Card is worth bookmarking. Any seller offering Mounjaro without requiring a prescription from a licensed UK prescriber is not a legitimate route. The GPhC register lets you verify any online pharmacy in seconds.

For a legally supplied, genuine product, the relevant question isn't which provider quotes the lowest number, it's which one gives you a thorough clinical assessment, a genuine supply chain, and someone qualified to call if something doesn't feel right. Our about page explains how we're structured; our clinical team page introduces the prescribers behind the reviews. On a prescription medicine, that context is part of the value, not a luxury on top of it.

If you're still weighing up whether Mounjaro is the right treatment for you, our weight-loss treatment overview covers how the different options compare. And if cost trends are your main question, our pages on whether Mounjaro prices are likely to fall, whether a reduction is on the horizon, what could drive the cost down, and whether prices are coming down now set out what's known and what's speculative.